Not a member? Register Now
By linking my Doximity account with UPMC Physician Resources, I acknowledge that:
By linking my Doximity account with UPMC Physician Resources, I acknowledge that:
Forgot your password? Enter the email address you used to create your account to initiate a password reset.
The Division of Pediatric Nephrology at UPMC Children’s Hospital of Pittsburgh provides a full range of services for the evaluation and management of children with simple or complex nephrologic or urologic disorders, including:
The physicians and staff of the Division of Pediatric Nephrology are well equipped to provide both acute and chronic management of various kidney problems and consultative services to other departments within the hospital and to community physicians. Inpatient and outpatient consultations are available for children with electrolyte and acid-base disorders. The division offers specialized procedures for renal replacement therapy including peritoneal dialysis and hemofiltration/hemo-diafiltration (CAVH/CVVH) for acute inpatients. Staff members work closely with urologic and pediatric surgeons to provide comprehensive management of patients.
UPMC Children’s Hospital of Pittsburgh performed its first pediatric kidney transplant in 1964. Since then, Children's transplant teams have performed the surgery on hundreds of children and young adults, making it one of the most active centers in the country. The program's objective is to restore health and wellness to children suffering from end-stage renal disease.
Children's Pediatric Kidney Transplant Program, managed by the pediatric nephrology department in cooperation with a surgical team, is one of the few programs in the world that uses FK506 (also known as Prograf and Tacrolimus) as its primary immunosuppressive agent. Using FK506 has enabled the program to achieve long term patient and graft survival rates that are among the best in the world.
We also have found that FK506 provides a better quality of life for transplant recipients. For instance, children on FK are routinely taken off steroid medications after the first 6-8 months of transplant. Avoiding long term steroid use prevents side effects such as stunted growth, hirsutism (facial and body hair), and gum enlargement.
The program at UPMC Children’s Hospital of Pittsburgh also includes living-related kidney transplantation and liver/kidney transplantation. Children's also performed the world's first living-related pediatric kidney/bone marrow transplant.
Children's Pediatric Kidney Transplantation Program is led by Christina Nguyen, MD.
To refer a patient, contact a clinical transplant coordinator at 412-692-5182.
One of the key missions of the Division of Pediatric Nephrology is to extend the knowledge of pathophysiology of renal disease through basic laboratory and clinical research. Key nephrology research includes an investigative focus on:
Ongoing extramural grants support the investigation of the genetic epidemiology of urinary tract abnormalities and of the genetic aspects of nephrotic syndrome and of focal glomerulosclerosis. These are all common and important disorders in children. In addition Children’s researchers are conducting a biomarker-based study of BK virus, a polyoma virus, as it relates to renal allograft injury after renal transplantation in childhood.
Other nephrology research involves a study of the basic mechanisms of apoptosis in proximal tubular epithelial cells exposed to albumin to mimic the effect of proteinuric disorders in general.
Additionally, a cutting-edge research study is being done on trafficking of the cystic fibrosis transmembrane regulator (CFTR) as it relates to chloride transport in renal epithelial cells. Another important study is investigating trafficking of nephrin in the glomerular basement membrane, an important structural protein that normally protects against proteinuria and nephrotic syndrome.
